The role of Fra-2 and SOX4 oncogene cascade in ATL and CTCLs

先前，我们已经表明Fra-2在CCR 4+成熟T细胞白血病/淋巴瘤（包括成人T细胞白血病/淋巴瘤（ATL）和皮肤T细胞淋巴瘤（CTCL））中持续表达并参与CCR 4表达以及细胞生长。在此，我们研究SOX 4在ATL和CTCL肿瘤发生中的表达和功能。Fra-2和SOX 4在ATL和CTCL的临床样品中一致地共表达。S 0X 4启动子分析表明Fra-2-JunD通过AP-1位点直接激活S 0X 4启动子。此外，SOX 4 siRNA显著抑制ATL和CTCL细胞系的细胞生长。我们发现，SOX 4敲低降低了GCKR、NAP 1和HDAC 8等基因的表达。我们还显示了SOX 4对HDAC 8启动子的直接激活。此外，HDAC 8敲低显著抑制ATL和CTCL细胞系的细胞生长。总之，这些发现表明Fra-2-S 0X 4途径在ATL和CTCL中具有重要的致癌作用。

Previously, we have shown that Fra-2 is consistently expressed and involved in CCR4 expression as well as cell growth in CCR4+ mature T-cell leukemias/lymphomas, including adult T-cell leukemia/lymphoma (ATL) and cutaneous T-cell lymphomas (CTCLs). Here, we we examine the expression and function of SOX4 in the oncogenesis of ATL and CTCLs. Fra-2 and SOX4 were consistently co-expressed in the clinical samples of ATL and CTCL. SOX4 promoter analysis demonstrated that Fra-2-JunD directly activates the SOX4 promoter via an AP-1 site. Furthermore, SOX4 siRNA significantly suppressed cell growth of ATL and CTCL cell lines. We found that SOX4 knockdown reduced the expression of genes such as GCKR, NAP1 and HDAC8. We also showed direct activation of the HDAC8 promoter by SOX4. Furthermore, HDAC8 knockdown significantly suppressed cell growth of ATL and CTCL cell lines. Taken together, these finding suggest that the Fra-2-SOX4 pathway has an important oncogenic role in ATL and CTCLs.